Scientists develop treatment for dry eye using human antibodies
Study participants who received eye drops containing human antibodies experienced reduced corneal damage
A new treatment for dry eye incorporating human antibodies was successful in reducing corneal damage in a small trial.
Write in The ocular surface, the researchers present the results of a study of 27 patients with severe dry eye.
Participants were randomly divided into two groups, one group receiving combined antibody-based eye drops and the other group receiving eye drops without antibodies.
Both groups administered the eye drops twice a day for eight weeks.
At the end of the trial period, there was a significant reduction in signs and symptoms of dry eye in the group given the drops containing antibodies, with no difference in tolerance or adverse events.
Dr Sandeep Jain, of the University of Illinois College of Medicine, pointed out that there are currently only two drugs approved for the treatment of dry eye.
“They don’t work for everyone, especially those with severe dry eye disease, so it’s very important to have a new drug that can treat the disease by targeting a different mechanism, in this case an auto- immunity, âhe explained.
Image credit: Pixabay / roegger